Tsapas A, Avgerinos I, Karagiannis T, Malandris K, Manolopoulos A, Andreadis P, Liakos A, Matthews DR, Bekiari E: Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Riechers DE, Irzyk GP, Jones SS, Fuerst EP 1997 Partial characterization of glutathione S-transferases from wheat (Triticum spp.) and purification of a safener-induced glutathione S-transferase from Triticum tauschii
Not all Part D plan members are eligible This demonstration is for beneficiaries who do not have a medically coverable indication to receive a GLP-1 through their Part D plan now, said a CMS official during a recent webinar about the program hosted by the National Community Pharmacists Association
After January 1, 2026, that pathway closed for adults 21 and older when the indication is weight loss alone